Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Neuprex enters pivotal trials

Oct. 18, 1996

Bristol-Myers Squibb obtains rights to Kyorin antibiotic

Oct. 18, 1996

Pfizer discloses polycyclic ether antibiotics

Oct. 18, 1996

IND filed for MiKasome

Oct. 11, 1996

Genes associated with latent CMV infection discovered

Oct. 11, 1996

Azole antifungals reported by Takeda

Oct. 11, 1996

Xoma poised to enter pivotal trials with Neuprex

Oct. 11, 1996

Cubist evaluating new class of antibacterial agents

Oct. 11, 1996

Daiichi discloses quinolone antibacterial agents

Oct. 11, 1996

Yamanouchi awaits marketing approval for Farom

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.